



CORTICOSTERIODS INDUCED ECCHYMOSIS 
Case Study 
 
JOSHISREE K. P.*1, RAJESH G.1, SIDDARAMA R.1 
1,2
Received: 24 Aug 2017 Revised and Accepted: 22 Nov 2017 
Department of Pharmacy Practice, Creative Educational Society’s College of Pharmacy, N H 4, Chinnatekur, Kurnool, Andhra Pradesh, 
India 518218 
Email: joshi5kopperla@gmail.com   
ABSTRACT 
Corticosteroids are the steroid hormones which are mainly used in the treatment of various diseases like rheumatoid arthritis, osteoarthritis, 
rheumatic fever, gout, allergic reactions, renal diseases and haematological diseases. Prolonged use of corticosteroids causes a number of 
undesirable effects. Major adverse drug reaction (ADR’s) includes ulcers/gastrointestinal bleeding, osteoporosis, increased risk of heart diseases 
and decreased in bone density. Here we report a case of male patient of 72years old who was confirmed with cervical osteoarthritis and using oral 
corticosteroid (OCS) (methylprednisolone) since 6 y. While the patient was on therapy ecchymosis was noticed. The relation between suspected 
drug and ADR was established by performing ADR assessment scale, whereas both de-challenge and re-challenge was done, and ADR assessment 
scales like Naranjo’s scale, WHO UMC scales showed probable ADR, it can be managed by stopping the drug or using alternative days. Close 
monitoring of blood cortisol levels in a patient using oral corticosteroids (OCS) should be done. 
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Ecchymosis is described as a large zone of skin discolouration 
caused by extravasation of blood into the subcutaneous tissue of the 
body. The onset discolouration of the skin is caused by the escape of 
the blood from ruptured blood vessels into the capillaries. 
Discolouration and exact colour of the skin represents the 
physiologic sequel of haemoglobin catabolism which is converted 
into bilirubin and hemosiderin. Ecchymosis is a common adverse 
effect associated with prolonged corticosteroid therapy. Senile 
purpura and corticosteroid-induced ecchymosis are similar and 
appear as large purple/brown blotches on the neck, face, or exterior 
surfaces of the arms and hands [1]. The pathophysiological 
mechanism of corticosteroid-induced ecchymosis is, after prolonged 
use of methylprednisolone leads to the destruction of the collagen 
support for small blood vessels which results in leakage of blood 
into surrounding tissues [2]. Prolong use of OCS also causes 
ulcers/gastrointestinal bleeding, osteoporosis, increased risk of 
heart disease and a decrease in bone density. 
Incidence: 22,909 people reported to have side effects when taking 
methylprednisolone. Among them, 57 people (0.25%) have 
ecchymosis [3]. 
CASE REPORT 
A 72 y old male patient admitted in cardiology department with 
chief complaints of severe neck pain, and brown blotches on exterior 
surfaces of both hands [persistent] since 2 mo, chest pain associated 
with sweating since 1 d. He was a known patient with cervical 
osteoarthritis [spondylitis] and he was using Methylprednisolone 
since 6 y. On general examination patient was conscious and 
coherent, his vitals shows blood pressure 100/70, pulse rate 84bpm, 
respiratory system (RS) shows clear. 
Investigations 
Laboratory examinations showed, haemoglobin 13.9 gm/dl, WBC 
12000cells/cum, blood urea 38 mg/dl, serum creatinine 1 mg/dl, 
ESR 18 mm/hr, SGOT 258u/l, SGPT 65 u/l, electrolytes shows 
sodium 138 mmol/l, potassium 3.9 mmol/l, chloride 130 mmol/l, 
RBS 142 mg/dl, total cholesterol 285 mg/dl, triglycerides 269 mg/dl, 
HDL 48.7 mg/dl, VLDL 53 mg/dl, LDL 146.8 mg/dl, CKMB 170 u/l, 
His serology tests showed negative.2D ECHO (EF 40%) shows 
coronary artery disease with moderate left ventricular dysfunction 
and ECG showed right bundle branch block (RBBB), antero-septal 
MI, T wave abnormality with possible anterior ischemia. Based on 
subjective and objective evaluation patient was experienced 
corticosteroid (Methylprednisolone) induced ecchymosis. Clinical 
evaluation was done and patient was treated symptomatically with 
Tab clavix+aspirin (75+325 mg)(for CAD), tab atorvastatin 40 
mg(lipid lowering), tab ranitidine 150 mg(antacid), tab 




After collecting past and present history of the patient, ADR analysis 
is done by using Naranjo’s scale, WHO-UMC scale, karch and lasagne 
scales shown in table 1, and the most suspected drug to produce 
ecchymosis due to OCS. Here we also performed severity, 
predictability and preventability scales shown in table 2. 
Re-challenge 
Patient has similar complaints from past, for confirmatory purpose 
we had reintroduced drugs methylprednisolone and aceclofenac+ 
tramadol, then he had experienced same symptoms like brown 
blotches on exterior surfaces i.e. in both hands. 
De-challenge 
After completion of the evaluation of re-challenge of suspected drugs 
were administered alternative days as he was with cervical 
osteoarthritis. 
DISCUSSION 
Corticosteroids (methylprednisolone) belongs to the class adrenal 
glucocorticoids. Mechanism shows it is a synthetic glucocorticoid, 
has potent anti-inflammatory activity in disorders of many organ 
systems and has sodium-retaining properties. It decreases the 
inflammatory cytokine cascade, inhibiting the activation of T cells, 
decreasing the extravasation of immune cells into the central 
nervous system, facilitating the apoptosis of activated immune cells, 
and indirectly decreasing the cytotoxic effects of nitric oxide and 
tumour necrosis factor alpha [2]. 
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The mechanism of corticosteroids induced ecchymosis is the 
destruction of the collagen support for small blood vessels which 
results in leakage of blood into surrounding tissues. Common 
symptoms of ecchymosis skin lesions shows petechial–small type of 
hematoma, pigmented purpuric dermatosis [2]. 
Few reports showed extensively with the occurrence of purpura, 
spontaneous ecchymosis or easy bruising after the administration of 
these corticosteroid hormones. Such skin lesions were noted in 
patients with arthritis who are receiving corticosteroids [4]. 
OCS causes numerous side effects like Cushing’s syndrome, peptic 
ulcer disease, osteoporosis, heart diseases like congestive heart 
disease (CHD).  
The duration of corticosteroids therapy in these conditions is often 
less than 1 mo, in contrast to the treatment of chronic respiratory 
diseases (asthma and Chronic obstructive pulmonary disease COPD), 
or autoimmune diseases (rheumatoid arthritis, systemic lupus 
erythematous, crohns disease and ulcerative colitis which can last 
for years [5]. 
 
 
Fig. 1: ECG shows right bundle branch block 
 
 
Fig. 2: Showed ecchymosis on both hands 
 
Table 1: Causality assessment scale 
S. No. Suspected drug Suspected ADR Naranjo’s scale WHO UMC Karchand lasagna 
1. Corticosteroid (methylprednisolone) Ecchymosis Probable ADR (6) Probable ADR Probable ADR 
 
Table 2: Severity, predictability and preventability of suspected ADR 
ADR Drug Severity Predictability Preventability 
Ecchymosis Methylprednisolone Severe level 4 Unpredictable ADR Unpreventable ADR 
 
CONCLUSION 
Daily use of corticosteroids (methyl-prednisolone) causes ecchymosis 
skin lesion in some patients. As corticosteroids may cause serious 
adverse effects, the Clinical pharmacist should play a major role in 
detecting, monitoring and managing of ADRs. Reducing the dose of 
the corticosteroids or using alternative day dosing may decrease the 
lesions effects. Precautions should be taken and proper monitoring 
of blood cortisol levels and WBC level for patients who receive OCS 
should be done. 
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